mouse α γ h2av antibodies (Developmental Studies Hybridoma Bank)
Structured Review

Mouse α γ H2av Antibodies, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 96/100, based on 96 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse α γ h2av antibodies/product/Developmental Studies Hybridoma Bank
Average 96 stars, based on 96 article reviews
Images
1) Product Images from "Neuronal progenitors suffer genotoxic stress in the Drosophila clock mutant per 0"
Article Title: Neuronal progenitors suffer genotoxic stress in the Drosophila clock mutant per 0
Journal: bioRxiv
doi: 10.1101/2024.08.13.607601
Figure Legend Snippet: a) Anti-γ-H2AV immune labelling (red) in CNS-squash preparations from 3 rd instar male larvae. DNA is stained with DAPI (white). Size bar = 5 μm. ZT=1. b) Proportion of cells showing anti-γ-H2AV immune signal in CNS-squash preparations from CS and per 0 3 rd instar male larvae. Fisher’s exact test, ****P<0.0001. Total number of cells, N = 1323, 985, respectively. ZT=1. c) Mitotic metaphases in CNS-squash preparations from 3 rd instar larvae. Left, CS , showing a normal metaphase. Right, chromosome aberration in per 0 . The yellow arrow indicates a chromosome fragment (break). The white arrow points to a fusion. 2, 3, 4 identify the autosomes. X, Y label the sex chromosomes. Size bar = 5 μm. ZT=2. d) Frequency of chromosome aberrations in CS and per 0 . Fisher’s exact test, ****P<0.0001. ZT=2. Total number of metaphases scored, N = 436, 527, respectively. e) PER overexpression rescues chromosome aberrations in per 0 . The overexpression of PER ( UASper16 ) using the pan-circadian per- and tim-GAL4 drivers drastically reduced the frequency of aberrations in an otherwise per 0 background. Chi-square= 49.50, df=3, ****P<0.0001. Total number of metaphases scored (from left to right), N = 337, 463, 345, 1021. ZT=2.
Techniques Used: Staining, Over Expression
Figure Legend Snippet: Treatment with vitamin C (VitC, 40 mM in standard medium, from embryo) reduced anti-γ-H2AV immune labelling (a-d) and chromosome aberrations (e) in per 0 3 rd instar larva males (a-e). a) Brain lobes (BLs) from 3 rd instar per + and per 0 male larvae obtained by reciprocal crossing (♀ CS x ♂ per 0 and vice versa ); anti-γ-H2AV on whole mount. Confocal maximum intensity projections. Dashed lines outline BLs. Size bar = 30 μm. ZT=2. b, c) Quantification of anti-γ-H2AV immune fluorescence intensity [relative signal intensity = (signal-background)/background] in whole mount CNS from 3 rd instar per + and per 0 male larvae as above. b & c show two independent experiments (imaged on different microscopes). Normal distribution of data was confirmed with the Shapiro-Wilk test. b) Top, BL (one per individual). Two-way ANOVA, Genotype (F 1, 43 =7.318, **P=0.0097), VitC treatment (F 1, 43 =4.732, *P=0.0352), Genotype x VitC treatment (F 1, 43 =1.617, P=0.2104). Tukey’s multiple comparisons test, per + vs . per 0 , *P=0.0282; per + VitC vs . per 0 , **P=0.0075; per 0 vs . per 0 VitC, *P=0.0196. Bottom, VNC. Two-way ANOVA, Genotype (F 1, 33 =23.75, ****P<0.0001), VitC treatment (F 1, 33 =5.241, *P=0.0286), Genotype x VitC treatment (F 1, 33 =3.044, P=0.0903). Tukey’s multiple comparisons test, per + vs . per 0 , ***P=0.0003; per + VitC vs . per 0 , ***P=0.0001; per 0 vs . per 0 VitC, **P=0.0066. ZT=1. c) Top, BL (one per individual). Two-way ANOVA, Genotype (F 1, 14 =21.03, ***P=0.0004), VitC treatment (F 1, 14 =40.05, ****P<0.0001), Genotype x VitC treatment (F 1, 14 =39.53, ****P<0.0001). Tukey’s multiple comparisons test, per + vs . per 0 , ****P<0.0001; per + VitC vs . per 0 , ****P<0.0001; per 0 vs . per 0 VitC, ****P<0.0001. Bottom, VNC. Two-way ANOVA, Genotype (F 1, 14 =46.94, ****P<0.0001), VitC treatment (F 1, 14 =12.97, **P=0.0029), Genotype x VitC treatment (F 1, 14 =7.040, *P=0.0189). Tukey’s multiple comparisons test, per + vs . per 0 , ***P=0.0001; per + VitC vs . per 0 , ****P<0.0001; per + VitC vs . per 0 , *P=0.0236; per 0 vs . per 0 VitC, **P=0.0011. Points show individual samples. Error bars = SD. ZT=1. d) Proportion of γ-H2AV immune positive cells in CNS squash preparations from 3 rd instar male larvae. Treatment with VitC did not affect CS (Fisher’s exact test, P=0.9209) but lowered the proportion of γ-H2AV immune labelled cells in per 0 (Fisher’s exact test, **P=0.0011). Total number of cells scored (from left to right), N = 912, 775, 295, 298. ZT=2. e) Proportion of chromosome aberrations in CNS squash preparations from 3 rd instar per + and per 0 male larvae obtained by reciprocal crossing (♀ CS x ♂ per 0 and vice versa ). Treatment with VitC lowered the proportion of chromosome aberrations. The effect was small in per + (Fisher’s exact test, P=0.1886) but highly significant in per 0 (Fisher’s exact test, ***P<0.0005). Total number of metaphases scored (from left to right), N = 468, 440, 439, 633. ZT=1. AOX overexpression rescues chromosome aberrations (f, g). f) Cartoon showing the position of the Alternative Oxidase (AOX) in the electron transport chain. g) The overexpression of AOX using the pan-circadian tim-GAL4 driver reduced the frequency of aberrations. The effect was marginal in per + (Fisher’s exact test, P=0.0663) but highly significant in per 0 (Fisher’s exact test, ***P<0.0009). Total number of metaphases scored (from left to right), N = 397, 387, 456, 412. ZT=1. Males obtained by reciprocal crossing [♀ UAS-AOX (per + ) x ♂ tim-GAL4 ( per 0 ) and vice versa ].
Techniques Used: Fluorescence, Over Expression